Table 2.
MLR results of risk factors of NAFLD according to serum APOA1 quintiles.
| APOA1 | n | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|---|
| Quartile | P value | OR (95% CI) | P value | OR(95% CI) | P value | OR (95% CI) | |
| Q1 | 3300 | 1 | 1 | 1 | |||
| Q2 | 3165 | <0.000 | 0.814 (0.731-.905) | 0.806 | 0.984 (0.869-1.115) | 0.479 | 1.055 (0.913-.220) |
| Q3 | 3156 | <0.000 | 0.568 (0.508-0.636) | 0.002 | 0.812 (0.711-0.927) | 0.005 | 0.790 (0.670-.932) |
| Q4 | 3202 | <0.000 | 0.382 (0.339-0.431) | <.0001 | 0.625 (0.539-0.724) | <.0001 | 0.562 (0.452-.699) |
Note: model 1 does not adjust for confounding factors; model 2 adjusted age, gender, and body mass index; model 3 adjusted age, sex, body mass index, waist circumference, uric acid, systolic blood pressure, diastolic blood pressure, total cholesterol, triacylglycerol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, fasting blood glucose, alanine aminotransferase, aspartate aminotransferase, and glutamyltranspeptidase.